Keyphrases
COVID-19
100%
Remdesivir
66%
Treatment Trials
37%
Hospitalized Adults
25%
Infectious Diseases
25%
Influenza
23%
COVID-19 Treatment
22%
Allergy Disease
21%
Confidence Interval
19%
Placebo
18%
Severe COVID-19
18%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Baricitinib
16%
Universal Vaccine
16%
Systematic Meta-analysis
16%
Meta-analysis
16%
COVID-19 Pandemic
16%
Randomized Controlled Trial
14%
Absolute Lymphocyte Count
13%
Immunomodulator
12%
Randomized Placebo-controlled Trial
11%
Risk Profile
11%
Nursing Homes
11%
Invasive Mechanical Ventilation
10%
Hazard Ratio
10%
National Institutes of Health
9%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
9%
Emerging Infectious Diseases
9%
Severe Disease
9%
Monoclonal Antibody
9%
Lessons Learned
8%
Underuse
8%
Disease Threat
8%
Multilineage
8%
Disease Stage
8%
Clinical Trial Data
8%
Guideline Dissemination
8%
Placebo-controlled Trial
8%
Meta-analysis of Randomized Controlled Trials
8%
COVID-19 Outcomes
8%
Pandemic Influenza Virus
8%
Treatment Algorithm
8%
Clinically Significant
8%
Doxycycline
8%
Therapeutic Landscapes
8%
Demographic Representation
8%
Primary Graft Dysfunction
8%
Phase II Trial
8%
Post-cardiac Surgery
8%
Survival Benefit
8%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
59%
Remdesivir
57%
Placebo
34%
Baricitinib
33%
Infection
33%
Coronavirinae
30%
SARS Coronavirus
25%
Pandemic
25%
Randomized Controlled Trial
23%
Immunomodulating Agent
14%
Secondary Infection
12%
Dexamethasone
11%
Immunocompromised Patient
10%
Clinical Trial
9%
Observational Study
9%
Corticosteroid
8%
Doxycycline
8%
COVID-19 Vaccine
8%
Quinolone Derivative
8%
Tolerability
8%
Live Attenuated Influenza Vaccine
8%
Therapeutic Use
8%
Respiratory Virus
8%
Multiple Myeloma
8%
Sudden Infant Death Syndrome
8%
Biological Marker
8%
Adverse Event
5%
Medicine and Dentistry
COVID-19
58%
Meta-Analysis
25%
Infection
22%
Infectious Disease
18%
Influenza Vaccine
16%
COVID-19 Vaccine
16%
Systematic Review
16%
Diseases
11%
Randomized Controlled Trial
10%
Observational Study
9%
Odds Ratio
9%
Post-Hoc Analysis
8%
Emerging Infectious Disease
8%
Cell Transplantation
8%
Cyclophosphamide
8%
Immunocompromised Patient
8%
Graft Failure
8%
Transplantation
8%
Corticosteroid
8%
Immunomodulating Agent
8%
Splenomegaly
8%
Wearable Sensor
8%
Remdesivir
8%
Heart Surgery
8%
Pandemic
8%
Influenza A Virus
8%
Artificial Respiration
8%
Cytopenia
8%
Mycobacterium Chimaera
8%
Sudden Infant Death Syndrome
8%
Lymphocytopenia
8%
Heart Rate Variability
6%
Corticosteroid Therapy
5%
Treatment Effect
5%
Sleep Time
5%
